Cgmquantify: Python and R Software Packages for Comprehensive Analysis of Interstitial Glucose and Glycemic Variability from Continuous Glucose Monitor Data
暂无分享,去创建一个
[1] J. H. Kim,et al. Glycemic Variability: How Do We Measure It and Why Is It Important? , 2015, Diabetes & metabolism journal.
[2] Gregory Forlenza,et al. cgmanalysis: An R package for descriptive analysis of continuous glucose monitor data , 2019, PloS one.
[3] Lo-Hua Yuan,et al. Translating glucose variability metrics into the clinic via Continuous Glucose Monitoring: a Graphical User Interface for Diabetes Evaluation (CGM-GUIDE©). , 2011, Diabetes technology & therapeutics.
[4] F. Ovalle,et al. Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes , 2009 .
[5] Ke Wang,et al. The digital biomarker discovery pipeline: An open-source software platform for the development of digital biomarkers using mHealth and wearables data , 2020, Journal of Clinical and Translational Science.
[6] J. Wojcicki,et al. “J”-Index. A New Proposition of the Assessment of Current Glucose Control in Diabetic Patients , 1995, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[7] Dandan Wang,et al. CGManalyzer: an R package for analyzing continuous glucose monitoring studies , 2018, Bioinform..
[8] Pratik Choudhary,et al. Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. , 2011, Diabetes technology & therapeutics.
[9] B. Kovatchev,et al. Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes , 2018, The American journal of the medical sciences.
[10] Ariel V. Dowling,et al. Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs) , 2020, npj Digital Medicine.
[11] Ariel V. Dowling,et al. Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs). , 2020, NPJ digital medicine.
[12] Boris P. Kovatchev,et al. Metrics for glycaemic control — from HbA1c to continuous glucose monitoring , 2017, Nature Reviews Endocrinology.
[13] M. de Groot,et al. Single Subject (N-of-1) Research Design, Data Processing, and Personal Science , 2017, Methods of Information in Medicine.
[14] L. Kessler,et al. Glucose Variability , 2016, Journal of diabetes science and technology.
[15] Boris Kovatchev,et al. Glycemic Variability: Risk Factors, Assessment, and Control , 2019, Journal of diabetes science and technology.